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318Risk index for predicting perioperative stroke,
myocardial infarction, or death risk in asymptomatic
patients undergoing carotid endarterectomy
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MPH,b Xiang Fang, MD,d Himani Gupta, MD,e Jason M. Johanning, MD,c and
Iraklis I. Pipinos, MD,c Madison, Wisc; and Omaha, Neb
Objective: The latest guidelines recommend performance of carotid endarterectomy (CEA) on asymptomatic patients with
high-grade carotid stenosis, only if the combined perioperative stroke, myocardial infarction (MI), or death risk is #3%.
Our objective was to develop and validate a risk index to estimate the combined risk of perioperative stroke, MI, or death
in asymptomatic patients undergoing elective CEA.
Methods: Asymptomatic patients who underwent an elective CEA (n [ 17,692) were identiﬁed from the 2005-2010
National Surgical Quality Improvement Program, a multicenter, prospective database. Multivariable logistic regression
analysis was performed with primary outcome of interest being the composite of any stroke, MI, or death during the
30-day periprocedural period. Bootstrapping was used for internal validation. A risk index was created by assigning
weighted points to each predictor using the b-coefﬁcients from the regression analysis.
Results: Fifty-eight percent of the patients were men with a median age of 72 years. Thirty-day incidences of stroke, MI, and
death were 0.9% (n[ 167), 0.6% (n[ 108), and 0.4% (n[ 72), respectively. The combined 30-day stroke, MI, or death
incidencewas 1.8% (n[324).Onmultivariable analysis, six independentpredictorswere identiﬁed and a risk index createdby
assigning weighted points to each predictor using the b-coefﬁcients from the regression analysis. The predictors included age
in years (<60: 0 point; 60-69:e1 point; 70-79:e1 point;$80: 2 points), dyspnea (2 points), chronic obstructive pulmonary
disease (3 points), previous peripheral revascularization or amputation (3 points), recent angina within 1 month (4 points),
and dependent functional status (5 points). Patientswere classiﬁed as low (<3%), intermediate (3%-6%), or high (>6%) risk for
combined30-day stroke,MI, ordeath, basedona total point scoreof<4,4-7, and>7, respectively.Therewere15,249patients
(86.2%) in the low-risk category, 2233 (12.6%) in the intermediate-risk category, and 210 (1.2%) in the high-risk category.
Conclusions: The validated risk index can help identify asymptomatic patients who are at greatest risk for 30-day stroke,
MI, and death after CEA, thereby aiding patient selection. (J Vasc Surg 2013;57:318-26.)The Asymptomatic Carotid Atherosclerosis Study
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://dx.doi.org/10.1016/j.jvs.2012.08.116asymptomatic carotid stenosis if CEA could be performed
with a <3% perioperative major morbidity and mortality
rate.1 This ﬁnding has been corroborated over the years,
and the selection of surgeons for the Carotid Revascular-
ization Endarterectomy versus Stenting Trial (CREST)
required that their rates of complications and death
be <3% among asymptomatic patients.2 Current Amer-
ican Heart Association/American College of Cardi-
ology/American Stroke Association/Society for Vascular
Surgery guidelines recommend (class IIa, level A
evidence) CEA in asymptomatic patients who have
>70% stenosis of the internal carotid artery, if the risk of
perioperative stroke, myocardial infarction (MI), and
death is low.3
These guidelines further recommend (class I, level C
evidence) that selection of asymptomatic patients for
carotid revascularization be guided by an assessment of
comorbid conditions, life expectancy, and other individual
factors and should include a thorough discussion of the
risks and beneﬁts of the procedure with an understanding
of patient preferences.3 The objective of our study was to
develop and validate a risk index to predict combined
30-day stroke, MI, or death risk in asymptomatic patients
undergoing elective CEA. This risk index would enable
an estimation of a patient’s perioperative risk after CEA
and thus aid in careful patient selection, which is essential
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METHODS
Dataset. Data were extracted from the 2005-2010
National Surgical Quality Improvement Program (NSQIP)
Participant Use Data Files.4 These are multicenter,
prospective databases with more than 250 participant
academic and community U.S. hospitals. In NSQIP,
a participating hospital’s surgical clinical reviewer (SCR)
captures data using a variety of methods, one of which is
medical chart abstraction. Events occurring after hospital
discharge are identiﬁed using comprehensive strategies.5 In
addition to examining inpatient medical records and
outpatient patient charts, a minimum of three attempts to
contact the patient by telephone or mail are made to ensure
accurate documentation of postdischarge events. If no
response is obtained, the Social Security Death Index and
the National Obituary Archives are queried to investigate
the potential of a death. Hospitals are required to provide
complete 30-day follow-up on at least 95% of patients.5 In
NSQIP, morbidity is identiﬁed by independent chart
review or patient encounter after patient discharge vs the
SVS Vascular Quality Initiative (Society of Vascular
Surgery, Chicago, Ill), where outcomes are tracked but
depend on self-reporting.
In NSQIP, the data are collected based on strict criteria
formulated by a committee. To ensure the data collected are
of high quality, the NSQIP has developed different training
mechanisms for the SCR and conducts an inter-rater reli-
ability audit of participating sites.4 Inter-rater reliability
audits show that overall disagreement rates on variables
was 1.56% (>140,000 audited ﬁelds) in 2008.6 The
processes of SCR training, inter-rater reliability auditing,
data collection, and sampling methodology have been
previously described in detail.4,7,8
Patients. Patients undergoing elective CEA in the
NSQIP datasets were identiﬁed using the American
Medical Association’s current procedural terminology
code for the procedure (35301) in combination with an
International Classiﬁcation of Diseases, Ninth Revision,
Clinical Modiﬁcation diagnosis code of occlusion and
stenosis of the carotid artery without mention of cerebral
infarction (433.10). To eliminate any potentially symptom-
atic patients, those with cerebrovascular accident with or
without residual neurologic deﬁcit, a history of transient
ischemic attack, impaired sensorium, coma, tumor in-
volving the central nervous system, hemiplegia/hemipare-
sis, paraplegia/paraparesis, or quadriplegia/quadriparesis
were excluded. Subsequently, to improve generalizability,
the following exclusion criteria were also applied: preoper-
ative do-not-resuscitate status, on ventilator prior to proce-
dure, ascites, esophageal varices, disseminated cancer, open
wound with or without infection, preoperative transfusion
of more than four units packed red blood cells, emergency
case classiﬁcation, chemotherapy within 30 days, radio-
therapy within 90 days, systemic sepsis within 48 hours,
contaminated/dirty wound class, cases with a simultaneousprocedure, and previous operation within 30 days. Preop-
erative data obtained included demographics, lifestyle,
comorbidity, functional status, and other variables.
Outcome. The primary outcome of interest was the
composite of any stroke, MI, or death during the 30-day
periprocedural period. This composite end point was
chosen based on recent guidelines of the American Heart
Association/American College of Cardiology/American
Stroke Association/Society for Vascular Surgery stating “It
is reasonable to perform CEA in asymptomatic patients
who have more than 70% stenosis of the internal carotid
artery if the risk of perioperative stroke, MI, and death is
low.”
Stroke has been deﬁned in the NSQIP database as
“Patient develops an embolic, thrombotic, or hemorrhagic
vascular accident or stroke with motor, sensory, or cogni-
tive dysfunction (for example, hemiplegia, hemiparesis,
aphasia, sensory deﬁcit, impaired memory) that persists
for 24 or more hours.”
Myocardial infarction has been deﬁned in the NSQIP
database as “Presence of one of the following: (1) docu-
mentation of electrocardiogram (ECG) changes indicative
of acute MI (one or more of the following): (a) ST eleva-
tion > 1 mm in two or more contiguous leads (b) new left
bundle branch (c) new Q-wave in two of more contiguous
leads or (2) new elevation in troponin greater than three
times upper level of the reference range in the setting of
suspected myocardial ischemia.”9
Deﬁnitions of relevant preoperative variables.
Chronic obstructive pulmonary disease (COPD) is deﬁned
by NSQIP as follows: “COPD (such as emphysema and/or
chronic bronchitis) resulting in any one or more of the
following: (1) Functional disability from COPD (eg, dysp-
nea, inability to perform activities of daily living); (2) hospi-
talization in the past for treatment of COPD; (3) requires
chronic bronchodilator therapy with oral or inhaled agents;
(4) a forced expiratory volume in 1 second of <75% of pre-
dicted on pulmonary function testing. Patients are not
included whose only pulmonary disease is asthma, an acute
and chronic inﬂammatory disease of the airways resulting in
bronchospasm. Patients with diffuse interstitial ﬁbrosis or
sarcoidosis are not included.”
Dyspnea is deﬁned by NSQIP as follows: “difﬁcult,
painful, or labored breathing” upon moderate exertion
(for example, is unable to climb one ﬂight of stairs without
shortness of breath) or at rest. The dyspneic patient is
subjectively aware of difﬁculty with breathing. The time
frame is within 30 days prior to surgery.
Previous peripheral revascularization or amputation
(PAD) is deﬁned by NSQIP as follows: “Any type of angio-
plasty (including stent placement) or revascularization
procedure for atherosclerotic peripheral vascular disease
(for example, aorta-femoral, femoral-femoral, femoral-
popliteal) or a patient who has had any type of amputation
procedure for peripheral vascular disease (for example, toe
amputations, transmetatarsal amputations, below-the-knee
or above-the-knee amputations). Patients who have had
amputation for trauma should not be included.”
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perform activities of daily living (ADLs) in the 30 days
prior to surgery. Activities of daily living are deﬁned as
‘the activities usually performed in the course of a normal
day in a person’s life. ADLs include bathing, feeding,
dressing, toileting, and mobility.” The patient is considered
independent if “the patient does not require assistance
from another person for any activities of daily living. This
includes a person who is able to function independently
with prosthetics, equipment, or devices.” If some assistance
is required, the patient is considered dependent.
Statistical analysis. Stepwise multivariable logistic
regression analysis was used to identify preoperative vari-
ables associated with increased risk of combined stroke,
MI, or death within 30 days of an elective CEA. The
P value entry and stay criteria for the logistic regression
model were .1 and .05, respectively. Interactions between
the signiﬁcant predictors were assessed.
Categorical predictors such as race were incorporated
into the model using reference coding. This means that
one level of the categorical predictor is chosen as a reference
category, and the remaining levels of the predictor are
compared with the reference. Statistical analysis was per-
formed using SAS (version 9.2; SAS Institute, Cary, NC).
P < .05 was considered signiﬁcant.
Risk model performance. The accuracy of the logistic
regression model was assessed by its discrimination and
calibration.10 Discrimination measures how well a model
can distinguish between cases (stroke/MI/death) vs non-
cases (favorable outcome). Discrimination was assessed
by c-statistic, also known as the area under the receiver-
operating characteristic curve. The c-statistic ranges from
0.50 (no better than ﬂipping a coin) to 1.00 (model is 100%
correct).
Calibration measures a model’s ability to generate
predictions that are close to the observed outcomes in the
data. The most widely used method for doing this for
hospital-based mortality models is the Hosmer-Lemeshow
test, which examines how well the percentage of observed
stroke/MI/death matches the percentage of predicted
stroke/MI/death over deciles of predicted risk.10
Risk model validation. Because predictive models
perform better on the data from which they were derived
than on new data, we performed bootstrap resampling to
obtain a bias-corrected c-statistic, thereby providing a
more accurate estimate of model performance in other
populations.11 This method of internal validation was
chosen over others, such as split-sample modeling, because
bootstrap resampling techniques have been shown to
produce stable and nearly unbiased estimates of predictive
accuracy, with better efﬁciency than other methods.11 For
this purpose, 1000 random bootstrap samples with
replacement and of the same size as the original sample
were drawn from the original dataset consisting of all
patients.
Development of risk index. Once the model was
developed using the regression equation, it was used to
develop a risk index. We used the methods described bySullivan et al12 to modify the parameter estimates of the
regression model into an index. The number of points
assigned to each variable equaled its regression coefﬁcient
divided by 0.2, followed by rounding to the nearest whole
number. Thus, the association of a variable assigned
2 points as twice as “strong” as that of a variable with
1 point but half as “strong” as that with 4 points. The
points for each risk factor were then summed to obtain the
total number of points for a patient.
To estimate the risk associated with each total point
score, the intercept in the regression equation (4.3392)
was added to 0.2 times the total point score to obtain bL.
The risk estimate for each total point score was then calcu-
lated using the formula for back-transforming from a
logistic regression estimated score to a probability, as:
Estimated probability percentage ¼ 100%  e
bL
1þ ebL
RESULTS
Median age of the 17,692 asymptomatic patients
(57.9% men) who underwent a CEA was 72 years. The
demographic characteristics, comorbidities, and laboratory
values are listed in Table I. Thirty-day incidences of stroke,
MI, and death were 0.9% (n ¼ 167), 0.6% (n ¼ 108), and
0.4% (n ¼ 72), respectively. The combined 30-day stroke,
MI, or death incidence was 1.8% (n ¼ 324). The 30-day
perioperative complications are listed in Table II.
On multivariable analysis (Table III), six independent
predictors for combined 30-day stroke, MI, or death
were identiﬁed and points assigned to them based on their
regression coefﬁcients: age in years (<60: 0 point; 60-69:
1 point; 70-79: e1 point; $80: 2 points), dyspnea at rest
or moderate exertion (2 points), COPD (3 points), PAD
(3 points), recent angina within 1 month (4 points), and
dependent functional status (5 points). Gender was not
a signiﬁcant predictor. The multivariable regression
model demonstrated moderate discrimination (c-statistic,
0.64; bias-corrected c-statistic, 0.64) and calibration
(Hosmer-Lemeshow test c2 ¼ 7.37; P ¼ .19). There was
not a signiﬁcant interaction (P > .05) between the signiﬁ-
cant predictors in the model.
The estimated risk for each patient was calculated by
adding the points assigned to each risk factor present in
the patient, thereby obtaining the point total for the
patient, and then using Table IV to calculate the risk.
Patients were classiﬁed as low (<3%), intermediate
(3%-6%), or and high (>6%) risk for 30-day stroke,
MI, or death based on a total point score of <4, 4-7,
and >7, respectively. There were 15,249 patients
(86.2%) in the low-risk category, 2233 (12.6%) in the
intermediate-risk category, and 210 (1.2%) in the high-
risk category.
Subgroup analysis for age. The higher risk for
combined 30-day stroke, MI, or death seen in patients
age “<60 years” compared with “60-69 years” and “70-
79 years” was further investigated using separate individual
Table I. Preoperative characteristics for the 2005-2010National Surgical Quality Improvement Program (NSQIP) dataset
Category Preoperative variable N (%)
Cardiac Angina within 1 month Yes 381 (2.2)
Cardiac surgery prior Yes 4279 (24.2)
Congestive heart failure Yes 120 (0.7)
Myocardial infarction (within 6 months) Yes 218 (1.2)
Percutaneous coronary intervention prior Yes 3481 (19.7)
Circulatory Bleeding disorder Yes 2497 (14.1)
Previous peripheral arterial revascularization or amputation Yes 1720 (9.7)
Rest pain in lower extremity Yes 121 (0.7)
General Age, years <60 1896 (10.7)
60-69 5465 (30.9)
70-79 6808 (38.5)
$80 3523 (19.9)
American Society of Anesthesiologists class 1 439 (2.5)
2 4641 (26.3)
3 11,238 (63.6)
4 1362 (7.7)
5 3 (0.02)
Body mass index, median (interquartile range), kg/m2 28.5 (25.4-32.3)
Corticosteroid use (chronic) Yes 319 (1.8)
Diabetes mellitus On insulin 2844 (16.1)
On medication 1934 (10.9)
Functional status Dependent 290 (1.6)
Hypertension Yes 15,144 (85.6)
Race American Indian 44 (0.3)
Asian/Paciﬁc Islander 176 (1.0)
Black 580 (3.3)
Hispanic 506 (2.9)
Unknown 1037 (5.9)
White 15,162 (86.6)
Sex Male 10,217 (57.9)
Female 7437 (42.1)
Systemic inﬂammatory response syndrome Yes 78 (0.5)
Transition (admitted from:) Home 17,520 (99.0)
Acute care 89 (0.5)
VA acute care 1 (0.01)
Chronic care 55 (0.3)
VA chronic care 0
Others 27 (0.2)
Weight loss >10% within 6 months Yes 71 (0.4)
Laboratory Albumin Abnormal 914 (5.2)
Alkaline phosphatase Abnormal 544 (3.1)
Blood urea nitrogen Abnormal 7310 (41.3)
Creatinine Abnormal 2197 (12.4)
Hematocrit Abnormal 3379 (19.1)
Platelets Abnormal 2360 (13.3)
Prothrombin time Abnormal 3311 (18.7)
Partial thromboplastin time Abnormal 1081 (6.1)
Serum glutamic oxaloacetic transaminase Abnormal 922 (5.2)
Sodium Abnormal 1950 (11.0)
White blood cell count Abnormal 1700 (9.6)
Renal Dialysis (preoperative) Yes 143 (0.8)
Respiratory COPD Yes 1755 (9.9)
Dyspnea At rest or moderate exertion 3310 (18.7)
Pneumonia (preoperative) Yes 14 (0.1)
Social Alcohol intake within last 2 weeks Yes 746 (4.2)
Smoking within past year Yes 4588 (25.9)
Therapy Anesthesia General 14,649 (82.8)
Regional 3040 (17.2)
COPD, Chronic obstructive pulmonary disease; VA, Veterans Affairs.
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“<60 years”was independently associated with a higher risk
for postoperative stroke than age “60-69 years” (odds ratio
[OR], 1.97; 95% conﬁdence interval [CI], 1.22-3.19)and “70-79 years” (OR, 2.01; 95% CI, 1.26-3.19) but
not $80 years (OR, 1.34; 95% CI, 0.82-2.19).
Although no difference was seen in the association with
postoperative MI between age “<60 years” and ages
Table II. Intraoperative/postoperative characteristics for the 2005-2010 National Surgical Quality Improvement
Program (NSQIP) dataset
Intraoperative/postoperative variables N (%)
Intraoperative
Anesthesia time, median (lower quartile-upper quartile), minutes 168 (137-204)
Operative time, median (lower quartile-upper quartile), minutes 107 (83-136)
Postoperative
Major complications
Cardiac Cardiac arrest 30 (0.2)
Myocardial infarction 108 (0.6)
Circulatory Postoperative packed red blood
cells transfusion >4 units
74 (0.4)
Graft Graft/prosthesis failure 13 (0.1)
Infection Sepsis 52 (0.3)
Septic shock 26 (0.2)
Neurologic Coma 12 (0.1)
Peripheral nerve deﬁcit 40 (0.2)
Stroke 167 (0.9)
Renal Acute renal failure 23 (0.1)
Renal insufﬁciency 21 (0.1)
Respiratory Pneumonia 119 (0.7)
Reintubation 134 (0.8)
Ventilator >48 hours 74 (0.4)
Return to operating room Return to operating room 768 (4.3)
Venous thromboembolism Deep venous thrombosis 26 (0.2)
Pulmonary embolism 23 (0.1)
Wound Deep wound infection 14 (0.1)
Wound dehiscence 23 (0.1)
Minor complications
Superﬁcial wound infection 73 (0.4)
Urinary tract infection 103 (0.6)
Other postoperative parameters
Length of stay for survivors, median (lower quartile-upper quartile), days 1 (1-2)
Mortality 72 (0.4)
Combined postoperative parameters
Stroke or death 225 (1.3)
Stroke, MI, or death 324 (1.8)
MI, Myocardial infarction.
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associated with lower risk for MI than age $80 years
(OR, 0.25; 95% CI, 0.10-0.63). Similarly, no difference
was seen in the association with postoperative death
between age “<60 years” and ages “60-69 years” and
“70-79 years.” Age “<60 years” was associated with lower
risk for postoperative death than age “$80 years” (OR,
0.30; 95% CI, 0.10-0.88).
Subgroup analysis for type of anesthesia. Subset
analysis was performed for regional and general anesthesia
with regard todyspnea andCOPD.Forpatientswho received
regional anesthesia, COPD remained a signiﬁcant predictor
(P ¼ .005); however, dyspnea dropped out (P ¼ .24). For
patients who received a general anesthetic, both remained
strong independent predictors (P < .0001 for both).
DISCUSSION
Three-fourths of the 117,000 CEAs done annually in
the United States are for asymptomatic disease.13 Given
the low rates of stroke for asymptomatic disease with
BMT alone, carotid revascularization is recommended
only if accompanied by low rates of perioperative complica-
tions.3 This necessitates careful patient selection based onpatient comorbidities and life expectancy. Since ACAS,
there has been a lack of objective tools for physicians,
neurologists, interventionalists, and surgeons to guide
them on patient selection.
Only one risk score estimating perioperative stroke and
death risk after CEA in asymptomatic patients based on
patient demographics and comorbidities exists.14 However,
it is based on 15-year-old population data, with periopera-
tive stroke and death rates >3%. Since then, there has
been a tremendous improvement in perioperative complica-
tion rates. As seen in our study, 30-day stroke and death
incidence after CEA in asymptomatic patients has decreased
to 1.3% in the United States, whereas 30-day stroke, MI,
or death incidence is low at 1.8%. Although overall
perioperative complication rates currently are low, there
are select subsets of patients with periprocedural risk >3%.
Careful patient selection necessitates identiﬁcation of
patients at low operative risk who may beneﬁt from CEA,
in contrast to patients at high risk, whose asymptomatic
carotid disease may be best suited to BMT alone.
In the present study with the largest published cohort of
asymptomatic patients, we identiﬁed risk factors associated
with 30-day stroke, MI, or death after CEA. The risk
Table III. Risk factors associated with combined 30-day stroke, myocardial infarction (MI), and death after carotid
endarterectomy (CEA) in asymptomatic patients on multivariate analysis
Risk factor Adjusted OR 95% CI
Regression
coefﬁcients
Points
assigned
Age, years
<60 Reference Reference Reference 0
60-69 (vs <60) 0.75 0.50-1.12 0.29 1
70-79 (vs <60) 0.84 0.57-1.24 0.17 1
$80 (vs <60) 1.52 1.03-2.26 0.42 2
Dyspnea at moderate exertion or rest
No Reference Reference Reference 0
Yes 1.43 1.10-1.86 0.36 2
Previous peripheral revascularization or amputation
No Reference Reference Reference 0
Yes 1.80 1.33-2.45 0.59 3
COPD
No Reference Reference Reference 0
Yes 1.73 1.27-2.36 0.55 3
Recent angina within 1 month
No Reference Reference Reference 0
Yes 2.05 1.21-3.47 0.72 4
Dependent functional status
No Reference Reference Reference 0
Yes 2.77 1.68-4.58 1.02 5
CI, Conﬁdence interval; COPD, chronic obstructive pulmonary disease; NSQIP, National Surgical Quality Improvement Program; OR, odds ratio.
Preoperative functional status has been deﬁned in the National Surgical Quality Improvement Program (NSQIP) as the ability to perform activities of daily
living in the 30 days before surgery. Activities of daily living are deﬁned as the activities usually performed in the course of a normal day in a person’s life; they
include bathing, feeding, dressing, toileting, and mobility.
COPD is deﬁned by the NSQIP as follows: “COPD (such as emphysema and/or chronic bronchitis) resulting in any one or more of the following: (1) functional
disability from COPD (eg, dyspnea, inability to perform activities of daily living); (2) hospitalization in the past for treatment of COPD; (3) requires chronic
bronchodilator therapy with oral or inhaled agents; (4) an forced expiratory volume in 1 second of <75% of predicted on pulmonary function testing.”
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and dependent functional status, and, using these, a risk
index was developed. Patients in the low-risk tier have a peri-
operative risk <3%, in contrast to intermediate- and high-
risk tier, with risk of 3%-6% and >6%, respectively.
Octogenarians have long been known to have higher
risk for perioperative stroke, MI, or death after CEA.15-17
These patients have been excluded from most trials due
to their higher perioperative risk and relatively shorter life
expectancy.18 ACAS and the Asymptomatic Carotid
Surgery Trial showed an absolute stroke risk reduction of
approximately 5% over 5 years,1,19 which necessitates
a long enough life expectancy for the beneﬁts to be realized.
Given the growing number of older adults and a current
life-table analysis that predicts that patients who survive to
the age of 80 to 85 years will live another 8 years on
average, the number of octogenarians who will require
CEA likely will increase exponentially in the near
future.20,21 The ﬁndings from our study show that other-
wise healthy octogenarians should not be denied CEA
solely based on their age. Although these patients are at
higher risk compared with younger patients, based on our
risk index, otherwise healthy octogenarians would still be
in the low-risk category with a perioperative risk <3%.
It was surprising to ﬁnd age “<60 years” to be
associated with a higher risk than “60-69 years” and “70-
79 years” (but lower risk than “$80 years”). A more
detailed analysis of the data for the age component of
our series indicates that the increased risk for patients“<60 years” was secondary to an increased risk for perio-
perative stroke in these patients. Although this ﬁnding
has not been previously demonstrated in major trials,
several studies have demonstrated that younger patients
have a higher incidence of stroke after CEA22 and a partic-
ularly “virulent” course after lower extremity surgical revas-
cularization, requiring frequent multiple interventions and
leading to a relatively poor limb salvage rate compared with
older patients who underwent similar surgical proce-
dures.23,24 We speculate that this probably is due to
more aggressive atherosclerotic and prothrombotic
processes in these patients.22,25,26
Previous studies on coronary revascularization have
shown PAD to be independently associated with adverse
postoperative outcomes.27 Previous peripheral revasculari-
zation or amputation encompasses such disease contributors
as tobacco use, diabetes, previous MI, heart failure, hyper-
tension, and obesity, and, as such, it is not surprising that
such patients were found be at an increased perioperative
risk.28 Furthermore, the recently described and still incom-
pletely understood association of PAD with a systemic
inﬂammatory state may further worsen the outcomes of
any carotid revascularization operation.29
Chronic obstructive pulmonary disease and severe
dyspnea are known to be associated with higher risk after
vascular surgery, in general, and CEA, in particular.15,30,31
Adverse surgical outcomes are more common in patients
with COPD as it leads to impairment of mucociliary clear-
ance, increased propensity for arrhythmias, and left
Table IV. Estimated risk of combined 30-day stroke,
myocardial infarction (MI), or death after carotid
endarterectomy (CEA) in asymptomatic patients
Total points
for the patient
Estimated risk
percentage for
the patient
Risk tier
categorization N (%)
1 1.18 Low
0 1.44
1 1.75 15,249 (86.2%)
2 2.13
3 2.6
4 3.15 Intermediate
5 3.82 2233 (12.6%)
6 4.63
7 5.6
8 6.75 High
9 8.13
10 9.75
11 11.66
12 13.88
13 16.45 210 (1.2%)
14 19.38
15 22.7
16 26.4
17 30.47
18 34.86
19 39.53
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324 Gupta et al February 2013ventricular dysfunction.32 Patients with recent angina are
predisposed to adverse cardiac events and were at higher
risk for adverse perioperative events. Dependent functional
status was associated with the highest risk for adverse peri-
operative outcomes after CEA, a ﬁnding that has been
previously shown after other vascular operations.14,15,31,33
Even with a favorable age proﬁle, these patients have a point
score $4, classifying them into intermediate or high risk,
with risk of adverse events >3%. A thorough risk-beneﬁt
analysis needs to be performed before considering these
patients for carotid revascularization.
This study based on the NSQIP database has many
strengths not seen in other studies. These include a large
sample size from a broad nationwide population that enables
smaller conﬁdence intervals in the assessment of risk factors.
It is based on data obtained from both academic and
community hospitals, includes data that have been indepen-
dently validated and audited, and takes into accountmultiple
preoperative variables. This is in contrast to the many
registry-based and Medicare analyses, which are primarily
administrative discharge datasets lacking the accuracy of
NSQIP because their data are not validated.
The present study has certain limitations. This study is
a retrospective analysis of prospectively recorded data. The
NSQIP was built for all surgeries and is not CEA speciﬁc;
thus, it does not take into account many factors that are
relevant to CEA. There is no information on the degree
of stenosis; the side of disease; presence of contralateral
occlusion; diagnostic imaging methods; preoperative stress
test and other cardiac workup; technical details of theprocedure, such as type of closure and use of shunts;
surgeon characteristics, including specialty and volume;
and lack of objective observer analysis for determination
of stroke after the procedure. Use of medications such as
antiplatelets, statins, and b-blockers is also not available
in the NSQIP dataset. Patients with certain comorbidities
may already have been pre-excluded from undergoing
a CEA due to presumed high risk, thus creating a sampling
bias. However, this bias exists for all risk estimation
tools,34,35 as these tools are based on a sample of patients
who have already undergone surgery and might have had
exclusions for presumed high risk. Lastly, discrimination
of the risk model (c-statistic) was only moderate, with
>0.8 considered excellent and <0.6 poor. It must be
remembered, however, that this is similar to all the previ-
ously existing risk assessment tools for vascular surgery
patients, such as Lee’s revised cardiac risk index and Gup-
ta’s cardiac risk calculator, which also show only moderate
discrimination.18,34 This could be due to the fact that as
the study case mix is restricted and patients become more
homogeneous (only one type of surgery), the c-statistic
tends to drop and thus is less informative.36
Current guidelines deﬁne MI as elevation of troponin
above the reference range. In this study, new elevation in
troponin >3 times the upper level of the reference range
in the setting of suspected myocardial ischemia was used
as the deﬁnition. Although this would lead to exclusion
of some MI, one can also argue that this makes MI a harder
end point as minor myocardial damage is excluded. This
approach of using a harder troponin end point to diagnose
MI has been previously validated and published.18
Current guidelines recommend CEA for asymptomatic
patients with high-grade internal carotid artery stenosis,
with the caveat that the expected postoperativemajor adverse
event rate be <3%, as beyond this, the advantage of carotid
revascularization over BMT diminishes. The risk index
proposed in this study would aid in identifying high-risk
patients. Patients in the low-risk category probably would
beneﬁt from CEA, in contrast with patients in the high-risk
category, who probably would beneﬁt from BMT. Thus,
we foresee this index as an objective adjunct to the clinician’s
subjective judgment in the patient selection process.
Apart from identifying high-risk patients, the risk index
can serve as an important tool in the informed consent
process. Accurate individualized assessment of perioperative
risk after CEA certainly would assist in the presentation of
adequate information regarding risks and beneﬁts. Physicians
have long quoted themost current literature to explain risks of
adverse outcomes associated with a procedure. This has not
always been an easy task, as each patient is different with
a unique set of risk factors. Thus, this risk index will simplify
the informed consent process by providing an estimate
of postoperative stroke, MI, and mortality risk after CEA.
CONCLUSIONS
The 30-day stroke and death incidence after CEA in
asymptomatic patients is 1.3% in the United States. A risk
index was developed classifying patients into low (<3%),
JOURNAL OF VASCULAR SURGERY
Volume 57, Number 2 Gupta et al 325intermediate (3%-6%), and high (>6%) risk for 30-day
stroke, MI, or death. The proposed validated risk index
can help identify the subgroup of asymptomatic patients
who are at greatest risk for 30-day stroke, MI, and death
after CEA, thereby aiding patient selection and informed
consent.
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